Hepatocellular Carcinoma Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
M
Not yet recruiting
  • Liver Cancer
  • +2 more
  • Standard microcatheter
  • PEDD device
  • Boston, Massachusetts
    Massachusetts General Hospital Cancer Center
2021-11-09
Nov 9, 2021
U
Not yet recruiting
  • Hepatocellular Carcinoma
    • La Tronche, Auvergne-Rhône-Alpes, France
      Anna M Borowik
    2021-11-18
    Nov 18, 2021
    N
    Not yet recruiting
    • Hepatocellular Carcinoma
    • Washington, District of Columbia
    • +1 more
    2021-11-18
    Nov 18, 2021
    N
    Not yet recruiting
    • Hepatocellular Carcinoma
    • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    2021-11-18
    Nov 18, 2021
    B
    Active, not recruiting
    • Hepatocellular Carcinoma
    • BR2008-1 (R)
    • BR2008 (T)
    • Osong, Korea, Republic of
      Bestian Hospital
    2021-11-18
    Nov 18, 2021
    N
    Enrolling by invitation
    • Hepatocellular Carcinoma
    • Optical Molecular Imaging
    • Indocyanine Green
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    2021-11-18
    Nov 18, 2021
    N
    Recruiting
    • Hepatocellular Carcinoma
    • +2 more
      • San Diego, California
      • +6 more
      2021-11-18
      Nov 18, 2021
      M
      Recruiting
      • Uterine Cervical Neoplasms
      • +7 more
      • Pembrolizumab/Vibostolimab Co-Formulation
      • +5 more
      • Duarte, California
      • +20 more
      2021-11-18
      Nov 18, 2021
      B
      Recruiting
      • Hepatocellular Carcinoma
      • Yang Yin Fu Zheng Jie Du therapy
      • Routine medical care
      • Beijing, Beijing, China
        Zhiyun Yang
      2021-11-12
      Nov 12, 2021
      U
      Recruiting
      • Hepatocellular Carcinoma
      • Atezolizumab (neoadjuvant)
      • +3 more
      • Amiens, France
      • +17 more
      2021-11-17
      Nov 17, 2021
      L
      Recruiting
      • Hepatocellular Carcinoma
      • Stereotactic Body Radiation
      • Transarterial Chemoembolization
      • London, Ontario, Canada
        London Health Sciences Centre, London Regional Cancer Program
      2021-11-10
      Nov 10, 2021
      U
      Recruiting
      • Hepatocellular Carcinoma
      • Bilirubinemia
      • Transarterial chemoembolization
      • Minneapolis, Minnesota
        University of Minnesota
      2021-11-15
      Nov 15, 2021
      S
      Completed
      • Hepatocellular Carcinoma
      • Guangzhou, Guangdong, China
        Cancer Center Sun Yat-sen University
      2021-11-14
      Nov 14, 2021
      H
      No longer available
      • Liver Cancer
      • +2 more
      • TheraSphere Treatment
      • Tampa, Florida
        H. Lee Moffitt Cancer Center and Research Institute
      2021-11-15
      Nov 15, 2021
      N
      Active, not recruiting
      • Biliary Tract Neoplasms
      • +4 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      2021-11-13
      Nov 13, 2021
      H
      S
      Not yet recruiting
      • Hepatocellular Carcinoma
      • +3 more
      • CAR-GPC3 T Cells
      • (no location specified)
      2021-11-02
      Nov 2, 2021
      E
      Recruiting
      • Hepatocellular Carcinoma
      • +3 more
      • ET140203 autologous T cell product
      • Duarte, California
      • +3 more
      2021-11-12
      Nov 12, 2021
      I
      Completed
      • Cervical Cancer
      • +20 more
      • Los Angeles, California
      • +3 more
      2021-11-12
      Nov 12, 2021
      S
      Recruiting
      • Advanced Solid Tumor
      • +2 more
      • Duarte, California
      • +20 more
      2021-11-10
      Nov 10, 2021
      M
      Recruiting
      • Hepatocellular Carcinoma
      • SIRT with Y-90 resin microspheres
      • Dallas, Texas
        Methodist Dallas Medical Center
      2021-11-09
      Nov 9, 2021